No Scientific Basis to Restrict 8 Weeks of Treatment with Ledipasvir/Sofosbuvir to Patients with HCV RNA <6,000,000 IU/ml

Ítems similars

• Sofosbuvir and Ledipasvir for HIV/HCV Co-infected Patients
  per: Rosenthal, Elana S., et al.
  Publicat: (2016)
• Reply: Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
  per: O’Brien, Thomas R., et al.
  Publicat: (2015)
• Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
  per: O'Brien, Thomas R., et al.
  Publicat: (2014)
• IFNL4 Genotype is Associated with Virologic Relapse After 8-Week Treatment with Sofosbuvir, Velpatasvir and Voxilaprevir
  per: O’Brien, Thomas R., et al.
  Publicat: (2017)
• Retreatment of HCV Genotype-1 with Sofosbuvir and Ledipasvir after Relapse with Sofosbuvir and Ribavirin: A Pilot Study
  per: Osinusi, Anu, et al.
  Publicat: (2014)